Landmark Bio is a one-stop cell and gene therapy CDMO based in Watertown, Massachusetts. The company was founded by Harvard University, the Massachusetts Institute of Technology, Cytiva, FUJIFILM Diosynth Biotechnologies, and Alexandria Real Estate Equities as a collective endeavor between academia, research hospitals, and the life sciences industry. From their state-of-the-art 44,000 sq. ft. integrated facility, they offer discovery and research, process development, analytical development, GMP Manufacturing, QC, and CMC development.
Visit Company Website
